CSL (CMXHF) Days Payable : 100.81 (As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is CSL Days Payable?

CSL's average Accounts Payable for the six months ended in Jun. 2024 was $1,882 Mil. CSL's Cost of Goods Sold for the six months ended in Jun. 2024 was $3,407 Mil. Hence, CSL's Days Payable for the six months ended in Jun. 2024 was 100.81.

The historical rank and industry rank for CSL's Days Payable or its related term are showing as below:

CMXHF' s Days Payable Range Over the Past 10 Years
Min: 30.4 Med: 39.9 Max: 78.01
Current: 78.01

During the past 13 years, CSL's highest Days Payable was 78.01. The lowest was 30.40. And the median was 39.90.

CMXHF's Days Payable is ranked worse than
62.89% of 714 companies
in the Biotechnology industry
Industry Median: 127.37 vs CMXHF: 78.01

CSL's Days Payable increased from Jun. 2023 (98.02) to Jun. 2024 (100.81). It may suggest that CSL delayed paying its suppliers.

CSL Days Payable Historical Data

The historical data trend for CSL's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL Days Payable Chart

CSL Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Days Payable

Get a 7-Day Free Trial

40.97

40.09

42.13

39.85

43.19

CSL Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial															94.57	86.59	98.02	91.13	100.81

Competitive Comparison of CSL's Days Payable

For the Biotechnology subindustry, CSL's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSL's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CSL's Days Payable distribution charts can be found below:

* The bar in red indicates where CSL's Days Payable falls into.

CSL Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

CSL's Days Payable for the fiscal year that ended in Jun. 2024 is calculated as

	Days Payable (A: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2023 )	+	Accounts Payable (A: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2024 )	*	Days in Period
=	( (820	+	867)	/	2 )	/	7129	*	365
=	843.5					/	7129	*	365
=	43.19

CSL's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (2897	+	867)	/	2 )	/	3407	*	365 / 2
=	1882					/	3407	*	365 / 2
=	100.81

CSL Days Payable Related Terms

Thank you for viewing the detailed overview of CSL's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

CSL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (OTCPK:CMXHF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

CSLLY:USA CSJA:Germany CSJ:Germany CSJ:Germany CSJ:Germany CSL:Australia

Address

655 Elizabeth Street, Melbourne, VIC, AUS, 3000

Website

https://www.csl.com

CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.